🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

At the St. Baldrick's Foundation event during the #COGFALL2024 mtg, Jason Glover & Daniel Blevins Braved the Shave! It's not too late to donate to help conquer kids' cancer: 2024 Children's Oncology Group Fall Meeting (PRIVATE EVENT) | A St. Baldrick's Event (stbaldricks.org)

Nivo+AVD led to longer progression-free survival than standard BV+AVD in adolescents & adults with stage III or IV advanced-stage classic Hodgkin lymphoma & had a better side-effect profile. Results of SWOG Cancer Research Network Children’s Oncology Group S1826 in NEJM. Jonathan Friedberg National Cancer Institute nejm.org/doi/10.1056/NE…

Your support helps #COG researchers advance toward better treatment for kids with cancer. Donate today! cog-foundation.networkforgood.com/projects/17654…

Presented at #ASH24: The addition of blinatumomab after induction chemotherapy in children with standard-risk disease of average or high risk of relapse significantly improved disease-free survival. Full AALL1731 trial results: nej.md/49CVkc1

B-ALL NEWS: Today, Amgen announced that Children’s Oncology Group will present study results for pediatric patients with B-cell precursor acute lymphoblastic leukemia (B-ALL) at ASH’s annual meeting, #ASH24. 🔗 Press release: amgen.ly/4g2K7Uq

Compared with #chemotherapy alone, the addition of #blinatumomab to standard intensity chemotherapy resulted in significantly superior DFS among children with both average- and higher-risk newly diagnosed B-cell #AcuteLymphoblasticLeukemia: ow.ly/G05950Umzf7 #ASH24

Original Article: Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children (AALL1731) nej.md/49CVkc1 #ASH24 | ASH

Exciting news from Children’s Oncology Group presented at #ASH24 showing incredible results by adding #blinatumomab to standard therapy in pediatric B-ALL. Congratulations to study co-chair and POGO board member @ZenSumit! This breakthrough in treating the most common childhood cancer is a

Over 15 #COG authors presented at ASH #ASH24 this weekend, including #AALL1731 study co-chairs Drs. Rau and Gupta at the plenary session! Congratulations to all the authors on their presentations!

The #COGF Newsletter - Winter 2024 is here! This edition covers #AALL1731, interviews on the importance of regional hospitals, Fourth and Goal's philanthropic support, Ewing Sarcoma Survivor story, & an interview with #COG ALL chair, Dr. David Teachey, thecogfoundation.org/news.html

In this Q&A w/ Children’s Oncology Group, Dr. David Teachey, who is also the #COG ALL Chair, discusses his career as well as the breakthrough #AALL1731 clinical trial that has transformed the standard of care across the globe for newly diagnosed children w/ B-ALL. More at: ms.spr.ly/6017onYzb.

The NCTN Cooperative Group Chairs are concerned about the impact of the proposed changes in the NIH & National Cancer Institute budgets; their support has enabled significant advances in #cancer treatment, leading to ~14M life-years saved for patients. Full statement: bit.ly/4k7aFpT

Please take a moment to read this incredibly important statement from our partners at @NRGOnc and all of the NCTN Group Chairs. The impact made by these groups is immeasurable. SWOG Cancer Research Network ECOG-ACRIN Cancer Research Group Alliance for Clinical Trials in Oncology Children’s Oncology Group

The #COGF Newsletter - Spring 2025 is here! This edition covers the road from idea to clinical trial, a foundations philanthropic support for kidney cancer research, an interview w/ Renal Chair, Nicholas Cost, & a letter from our Group Chair, Doug Hawkins. thecogfoundation.org/news.html

The #COG has endorsed a #clinical practice guideline on Less Restrictions in Daily Life in March 2025. This was developed by the Dutch Children's Oncology Group. #DCOG childrensoncologygroup.org/docs/default-s…

RFP - Provision of professional consulting services in brand strategy for COG - Proposal due July 4, 2025. To see more details: childrensoncologygroup.org/docs/default-s…

#COG celebrates Clinical Trials Day!